These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4163175)

  • 1. Histamine release from leukocytes of hypersensitive individuals. II. Reduced sensitivity of leukocytes after injection therapy.
    Pruzansky JJ; Patterson R
    J Allergy; 1967 Jan; 39(1):44-50. PubMed ID: 4163175
    [No Abstract]   [Full Text] [Related]  

  • 2. Capacity of purified antigens and whole pollen extracts to release histamine from leukocytes of hay fever patients.
    Norman PS; Lichtenstein LM
    J Allergy Clin Immunol; 1973 Aug; 52(2):94-104. PubMed ID: 4124985
    [No Abstract]   [Full Text] [Related]  

  • 3. Nasal secretory antibody to inhalant allergens in allergic and non-allergic patients.
    Turk A; Lichtenstein LM; Norman PS
    Immunology; 1970 Jul; 19(1):85-95. PubMed ID: 4098597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies in pollen allergy. II. Comparison of leucocyte sensitivity and levels of blocking antibody in hay fever subjects administered allpyral or pollaccine.
    Weinstock M; Starr MS
    Int Arch Allergy Appl Immunol; 1970; 37(4):385-92. PubMed ID: 4188972
    [No Abstract]   [Full Text] [Related]  

  • 5. Histamine release: in vitro studies of the inhibitory region of the dose-response curve.
    Magro AM; Alexander A
    J Immunol; 1974 May; 112(5):1762-5. PubMed ID: 4131874
    [No Abstract]   [Full Text] [Related]  

  • 6. Leukocyte histamine release in clinical assessment of subjects with ragweed respiratory allergy.
    McCourtie DR; Elder HW; Broder I
    Int Arch Allergy Appl Immunol; 1973; 44(2):294-301. PubMed ID: 4122304
    [No Abstract]   [Full Text] [Related]  

  • 7. Maintenance immunotherapy in ragweed hay fever. Booster injections at six week intervals.
    Norman PS; Winkenwerder WL; Lichtenstein LM
    J Allergy; 1971 May; 47(5):273-82. PubMed ID: 4102487
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies in pollen allergy. I. A method for estimating histamine release from sensitised leucocytes in the presence of serum.
    Starr MS; Weinstock M
    Int Arch Allergy Appl Immunol; 1970; 37(3):239-47. PubMed ID: 4188944
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies in pollen allergy. 3. The relationship between blocking antibody levels and symptomatic relief following hyposensitisation with allpyral in hay fever subjects.
    Starr MS; Weinstock M
    Int Arch Allergy Appl Immunol; 1970; 38(5):514-21. PubMed ID: 4191851
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and immunologic studies of ragweed immunotherapy.
    Melam H; Pruzansky J; Patterson R; Singer S
    J Allergy; 1971 May; 47(5):262-72. PubMed ID: 4102486
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlations between clinical symptoms, leukocyte sensitivity, antigen-binding capacity, and Prausnitz-Küstner activity in a longitudinal study of ragweed pollinosis.
    Melam HL; Pruzansky JJ; Patterson R
    J Allergy; 1970 Nov; 46(5):292-9. PubMed ID: 4098121
    [No Abstract]   [Full Text] [Related]  

  • 12. [Histamine release from human leukocytes after treatment with 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) and its structural analogs].
    Orlov SM; Kulikov VI; Pol'ner AA; Bergel'son LD
    Biokhimiia; 1985 Apr; 50(4):680-5. PubMed ID: 2408682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basophil histamine release, IgE, eosinophil counts, ECP, and EPX are related to the severity of symptoms in seasonal allergic rhinitis.
    Winther L; Moseholm L; Reimert CM; Stahl Skov P; Kaergaard Poulsen L
    Allergy; 1999 May; 54(5):436-45. PubMed ID: 10380774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteria and their products peptidoglycan and teichoic acid potentiate antigen-induced histamine release in allergic patients.
    Norn S; Jarløv JO; Jensen CB; Clementsen P; Dahl BT; Espersen F; Stahl Skov P
    Agents Actions; 1987 Apr; 20(3-4):174-7. PubMed ID: 2440264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro studies of human reaginic allergy.
    Osler AG; Lichtenstein LM; Levy DA
    Adv Immunol; 1968; 8():183-231. PubMed ID: 4174134
    [No Abstract]   [Full Text] [Related]  

  • 16. [The in-vitro histamine liberation in human leukocytes sensitized by grass pollen. Pharmacological application of the study on racephedrine and theophylline (proceedings)].
    Biot N; Kofman J; Grosclaude M; Perrin-Fayolle M
    Acta Allergol; 1977 Jun; 32(3):221-2. PubMed ID: 70946
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies of histamine release from human leukocytes.
    Levy DA
    Ann Allergy; 1969 Oct; 27(10):511-8. PubMed ID: 4195891
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent laboratory evidence of benefits from injection therapy for pollinosis.
    Marinkovich V
    Northwest Med; 1970 Jun; 69(6):40. PubMed ID: 4193906
    [No Abstract]   [Full Text] [Related]  

  • 19. Absorption of reagin by human tissues in vitro.
    Parish WE
    Int Arch Allergy Appl Immunol; 1970; 37(2):184-96. PubMed ID: 4189003
    [No Abstract]   [Full Text] [Related]  

  • 20. Leukocyte histamine release and humoral changes during oral and subcutaneous hyposensitization of grass pollen allergic children.
    Wahn U; Maasch HJ; Geissler W
    Helv Paediatr Acta; 1984 May; 39(2):137-44. PubMed ID: 6085730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.